home / stock / clpt / clpt quote
Last: | $5.33 |
---|---|
Change Percent: | 0.74% |
Open: | $5.35 |
Close: | $5.33 |
High: | $5.49 |
Low: | $5.25 |
Volume: | 129,079 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.33 | $5.35 | $5.33 | $5.49 | $5.25 | 129,079 | 04-19-2024 |
$5.39 | $5.55 | $5.39 | $5.69 | $5.35 | 86,697 | 04-18-2024 |
$5.53 | $5.515 | $5.53 | $5.67 | $5.469 | 137,965 | 04-17-2024 |
$5.58 | $5.55 | $5.58 | $5.7699 | $5.516 | 113,266 | 04-16-2024 |
$5.61 | $5.93 | $5.61 | $6.09 | $5.35 | 304,738 | 04-15-2024 |
$5.81 | $6.16 | $5.81 | $6.23 | $5.72 | 194,346 | 04-12-2024 |
$6.2 | $6.23 | $6.2 | $6.28 | $6.0983 | 58,081 | 04-11-2024 |
$6.16 | $6.13 | $6.16 | $6.3232 | $6.02 | 101,295 | 04-10-2024 |
$6.38 | $6.3 | $6.38 | $6.39 | $6.22 | 74,200 | 04-09-2024 |
$6.28 | $6.48 | $6.28 | $6.5299 | $6.19 | 139,598 | 04-08-2024 |
$6.43 | $6.39 | $6.43 | $6.53 | $6.32 | 57,354 | 04-05-2024 |
$6.38 | $6.61 | $6.38 | $6.71 | $6.32 | 86,870 | 04-04-2024 |
$6.6 | $6.42 | $6.6 | $6.64 | $6.37 | 65,358 | 04-03-2024 |
$6.45 | $6.57 | $6.45 | $6.57 | $6.36 | 97,571 | 04-02-2024 |
$6.73 | $6.81 | $6.73 | $6.81 | $6.481 | 78,236 | 04-01-2024 |
$6.8 | $6.72 | $6.8 | $6.92 | $6.655 | 84,050 | 03-29-2024 |
$6.8 | $6.72 | $6.8 | $6.92 | $6.655 | 84,050 | 03-28-2024 |
$6.72 | $6.59 | $6.72 | $6.72 | $6.54 | 83,948 | 03-27-2024 |
$6.54 | $6.75 | $6.54 | $6.77 | $6.5 | 133,640 | 03-26-2024 |
$6.74 | $6.57 | $6.74 | $6.82 | $6.445 | 167,048 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
SOLANA BEACH, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner AviadoBio on treating its firs...
SOLANA BEACH, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner PTC Therapeutics on completion...
SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its fourth quarter and f...